Pepsins, peptic activity, and peptic inhibitors

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Information on gastric pepsinogen and peptic activity is limited due to heterogeneity and lack of specific assays.
• Peptic activity generally parallels gastric acid output, offering limited additional clinical insight.
• Inhibiting peptic activity is vital for pharmacotherapy of peptic ulcer disease.

Purpose of the Study:

• To highlight the importance of inhibiting peptic activity in peptic ulcer disease treatment.
• To outline various strategies for inhibiting pepsin's role in gastric juice.

Main Methods:

• Review of current understanding of pepsinogen and pepsin.
• Discussion of therapeutic strategies targeting pepsin activity.

Main Results:

• Inhibition of gastric acid and pepsinogen secretion, raising gastric pH, and inhibiting pepsin-substrate binding are effective.
• These strategies accelerate the healing rate of peptic ulcers.

Conclusions:

• Effective inhibition of peptic activity is key in managing peptic ulcer disease.
• Multiple pharmacotherapeutic approaches can be employed to reduce pepsin's impact.
• Acid suppression, pH elevation, and pepsin binding inhibition promote ulcer healing.